NCT06924684进行中（未招募）2 期
Efficacy Of High-Dose Rosuvastatin Preloading Before Primary Percutaneous Coronary Intervention In Patients Suffering From St-Elevation Myocardial Infarction
干预措施
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 66
- 试验地点
- 2
- 主要终点
- Incidence of MACE
研究概览
简要总结
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Care Provider)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18-75 years Patients undergoing primary angiography
排除标准
- •Hemodynamically unstable patients. History or clinical evidence of any co-morbidities. Taking any medications regularly even statins.
研究组 & 干预措施
Intervention arm
Active Comparator
Tab Rosuvastatin 40mg at presentation. Tab Rosuvastatin 20mg at night for 30 days.
干预措施: Statin monotherapy (rosuvastatin or atorvastatin) (Drug)
Placebo Arm
Placebo Comparator
Placebo capsule 40mg (weight) at presentation. Tab Rosuvastatin 20mg at night for 30 days.
干预措施: Placebo (Drug)
结局指标
主要结局
Incidence of MACE
时间窗: 30 days
In-Hospital mortality
时间窗: 30 days
次要结局
未报告次要终点
研究者
Sohaib Ashraf
Senior Registrar, Deparment of Cardiology, Principal Investigator
Sheikh Zayed Federal Postgraduate Medical Institute
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) StudyA Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.NCT01971606Yonsei University234
Unknown
3 期
Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention StudyCoronary Artery DiseaseNCT01378715University Hospital, Motol400
已完成
3 期
ROsuvastatin LOading and Clinical Outcomes TrialAtherosclerosisNCT01936805Yuksek Ihtisas Hospital299
Unknown
不适用
Effect of Statin Preloading in STEMI in Improving PCI OutcomesST Elevation Myocardial InfarctionNCT04974814Beni-Suef University99
已完成
3 期
ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin ReloadingAssess the Periprocedural Myocardial NecrosisNCT01228227Gennaro Sardella310